Performing more than one gene edit, in sequence as part of a single process or therapy – for example, multiple knockout edits or a knockout edit followed by a targeted gene insertion. Intellia has developed a proprietary sequential genome editing process in primary human T cells that can lead to the knockout of multiple genes.